Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: April 2012

March Was Another Important Month for FluoroPharma Medical, Inc. (FPMI)

Posted on April 2, 2012 by MissionIR

In March, when FluoroPharma Medical, a developer of unique imaging agents for use with positron emission tomography (PET), filed their 10-K for fiscal 2011, there were no surprises, leading Zack’s Investment Research to reaffirm its $2.00 price target and recommendation … Continue reading →

Posted in FluoroPharma Medical Inc. FPMI | Leave a comment

RadNet, Inc. (RDNT) Acquires California-Based West Coast Radiology

Posted on April 2, 2012 by MissionIR

RadNet is the largest provider of fixed-site outpatient diagnostic imaging services in the United States. The company has a network of 233 owned and/or operated facilities in its core markets of California, New York, New Jersey, Maryland, Delaware, and Rhode … Continue reading →

Posted in Small Cap News | Leave a comment

Wave Systems Corp. (WAVX) Enters Strategic Milestone Distribution Agreement with Vigil Software

Posted on April 2, 2012 by MissionIR

Wave Systems has established a strong position in enterprise network endpoint encryption technologies, with offerings like the EMBASSY® Remote Administration Server (ERAS) that gives businesses a powerful solution to costly, time-consuming, full-disk encryption (FDE) methods like deploying self-encrypting drives (SEDs) … Continue reading →

Posted in Small Cap News | Leave a comment

China Sunergy Co. Ltd. (CSUN) and KDG Energy Begin Assembly of Solar Modules

Posted on April 2, 2012 by MissionIR

China Sunergy recently announced that it has begun assembling solar modules in France through OEM cooperation with KDG Energy, a manufacturer of high-quality PV modules. Both parties entered into a memorandum of understanding in November 2011. The memorandum states that … Continue reading →

Posted in Small Cap News | Leave a comment

Smith Medical Partners Announces Logistics Agreement for Cardium Therapeutic Inc.’s (CXM) National Distribution of Excellagen™

Posted on April 2, 2012 by Mission IR

Smith Medical Partners, the specialty pharmaceutical subsidiary of H. D. Smith, today announced an exclusive logistics and cold chain services agreement with Cardium Therapeutics, a health sciences and regenerative medicine company, to support its recently launched wound care product, Excellagen™.  … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Cardium Therapeutics, Inc. (CXM) Announces U.S. Intro of Excellagen

Posted on April 2, 2012 by MissionIR

Friday, Cardium Therapeutics announced Excellagen’s introduction into U.S. markets. Excellagen is a wound care product for dermal wounds, such as diabetic foot ulcers and other types of pressure ulcers. Cardium is focused on the acquisition and development of new bio-medical … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment